CN114369048B - Method for catalytic synthesis of astaxanthin - Google Patents
Method for catalytic synthesis of astaxanthin Download PDFInfo
- Publication number
- CN114369048B CN114369048B CN202111569916.5A CN202111569916A CN114369048B CN 114369048 B CN114369048 B CN 114369048B CN 202111569916 A CN202111569916 A CN 202111569916A CN 114369048 B CN114369048 B CN 114369048B
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- compound
- ethanol
- reaction
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 62
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 62
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 61
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 49
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims abstract description 30
- 238000007036 catalytic synthesis reaction Methods 0.000 title claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 39
- 239000003513 alkali Substances 0.000 claims abstract description 32
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002585 base Substances 0.000 claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 18
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims abstract description 17
- 239000011541 reaction mixture Substances 0.000 claims abstract description 12
- 238000001816 cooling Methods 0.000 claims abstract description 10
- 239000002253 acid Substances 0.000 claims abstract description 9
- 238000006386 neutralization reaction Methods 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- 239000012074 organic phase Substances 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 82
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 61
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 8
- 229960000583 acetic acid Drugs 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000012362 glacial acetic acid Substances 0.000 claims description 7
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 6
- 239000001632 sodium acetate Substances 0.000 claims description 6
- 235000017281 sodium acetate Nutrition 0.000 claims description 6
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 claims description 6
- 229940039790 sodium oxalate Drugs 0.000 claims description 6
- 239000004280 Sodium formate Substances 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 claims description 4
- 235000019254 sodium formate Nutrition 0.000 claims description 4
- 239000012456 homogeneous solution Substances 0.000 claims description 3
- 238000006317 isomerization reaction Methods 0.000 claims description 3
- 235000011056 potassium acetate Nutrition 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 claims description 2
- 238000000605 extraction Methods 0.000 abstract description 7
- 238000000926 separation method Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 17
- 239000000463 material Substances 0.000 description 14
- 230000002194 synthesizing effect Effects 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- MQZIGYBFDRPAKN-UWFIBFSHSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-UWFIBFSHSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 238000006555 catalytic reaction Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 239000012065 filter cake Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 239000011259 mixed solution Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 238000009835 boiling Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000011010 flushing procedure Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 238000000967 suction filtration Methods 0.000 description 5
- 238000005292 vacuum distillation Methods 0.000 description 5
- 238000001291 vacuum drying Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 238000007239 Wittig reaction Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 239000003444 phase transfer catalyst Substances 0.000 description 2
- 150000003003 phosphines Chemical class 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- UAEPNZWRGJTJPN-UHFFFAOYSA-N Methylcyclohexane Natural products CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- -1 alkali metal alkoxides Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 150000001934 cyclohexanes Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A method for catalytic synthesis of astaxanthin, comprising the steps of: 1) Placing the compound II and the compound III together in a solvent according to a molar ratio of 2.05-2.1:1, adding weak base, stirring, mixing and cooling to a temperature of-25 ℃ to-10 ℃; 2) Dropwise adding alkali liquor into the reaction mixture of the step 1) in a continuous mode at the temperature of minus 25 ℃ to minus 10 ℃, wherein the molar ratio of alkali in the alkali liquor to the compound II is 1.4-2.5:1; 3) After the reaction is completed, acid is added for neutralization, extraction and separation are carried out, and an organic phase is concentrated to obtain the compound I.
Description
Technical Field
The invention relates to a cyclohexane derivative with at least four carbon atoms and an acyclic unsaturated side chain substituted by a six-membered non-aromatic ring, in particular to a preparation method of astaxanthin.
Background
Astaxanthin, also known as Astaxanthin, is a fat-soluble carotenoid known by the english name Astaxanthin and by the chemical name 3,3' -dihydroxy-4, 4' -diketo-beta, beta ' -carotene of formula C 40 H 52 O 4 The molecular weight 596.86 is a reddish brown to brown powder, and has high heat resistance and poor light resistance. It has unique coloring function, oxidation resistance, cancer resistance, ultraviolet injury resistance and other functions, and may be used widely in food, feed, cosmetics, medicine and other fields. The chemical structure is formed by connecting four isoprene units in conjugated double bond form, and two isoprene unit groups are arranged at two endsThe six-section ring structure is formed as follows:
the chemical synthesis process route of astaxanthin has the advantage of lower cost, and the synthesis route is as follows: 2c15+c10=c40; c20+2c10=c40; three synthetic routes of canthaxanthin as raw material. 2c15+c10=c40 is a main route for industrial production of astaxanthin, which adopts a reaction of C15 phosphine salt and C10 dialdehyde to generate WITTIG under the action of alkali, the alkali is mainly strong base, such as hydroxide or alkoxide of alkali metal as described in patent document DE19509955A1, and patent document CN101454280B uses strong alkali sodium methylate, but the strong alkali is too strong in the process of synthesizing astaxanthin, which can cause the generation of byproducts such as astaxanthin and half shrimp, thereby reducing the yield of the reactants, ensuring that the reaction conditions are not easy to control, ensuring strict control requirements of the reaction conditions, and having certain difficulty in industrial production. The synthetic method of final formation of astaxanthin by WITTIG reaction using butylene oxide as a weak base has been reported (eur.j. Org. Chem.2000, 829-836), and the advantage of using a weak base butylene oxide is that anions of phosphine salts (e.g. bromide ions) are trapped and thus chemically bonded, but butylene oxide is a relatively expensive carcinogen and is flammable and explosive in itself, and is more unsuitable for use in green-lasting chemical production. For this reason, further improvement of the synthetic astaxanthin route 2c15+c10=c40, and improvement of the reaction yield is a problem to be solved in the prior art.
Disclosure of Invention
Aiming at the problems, the invention provides a method for synthesizing astaxanthin by catalysis, which has the advantages of simple and safe catalyst source, high yield, easy control of process conditions, less side reaction and the like.
In order to solve the problems, the technical scheme provided by the invention is as follows:
a method for synthesizing astaxanthin by catalysis,
the reaction is as follows
The method comprises the following steps:
a method of catalytically synthesizing astaxanthin, the method comprising the steps of:
1) Dissolving a compound II and a compound III in a solvent, adding weak base, stirring, mixing and cooling at-25 ℃ to-10 ℃;
2) Adding strong alkali solution into the reaction mixture in the step 1) at the temperature of between 25 ℃ below zero and 10 ℃ below zero to react;
3) After the reaction is completed, acid is added for neutralization, extraction and separation are carried out, and an organic phase is concentrated to obtain the compound I.
The method for synthesizing astaxanthin by catalysis comprises the following steps: in step 1), the weak base is selected from sodium salt or potassium salt of organic weak acid, preferably the weak base is selected from one or more of sodium benzoate, sodium phenolate, sodium formate, sodium oxalate, sodium acetate, potassium benzoate, potassium formate, potassium oxalate and potassium acetate.
The method for synthesizing astaxanthin by catalysis comprises the following steps: in step 2), the strong base solution is a homogeneous solution or suspension selected from the group consisting of alkali metal alkoxides, alkali metal hydroxides, butyl lithium; the strong alkali solution is a homogeneous solution or suspension of sodium hydroxide or potassium hydroxide in ethanol, the ethanol for preparing the strong alkali solution has a water content of 8-10% by weight, and the mass ratio of the strong alkali solution to dichloromethane in the solvent is 0.7-0.8: 1.
the molar ratio of the alkali in the strong alkali solution to the compound II is 1.4-2.5:1, preferably 1.4-1.8:1.
The method for synthesizing astaxanthin by catalysis comprises the following steps: in the step 1), the molar ratio of the compound II to the compound III is 2.0-2.2:1; the molar ratio of the weak base to the compound II is 0.5-1.5: 1, preferably 0.8 to 1.2:1.
the method for synthesizing astaxanthin by catalysis comprises the following steps: in step 1), the solvent is selected from an alcohol solvent, a mixture of different alcohol solvents or a mixed solvent consisting of an alcohol and a non-polar solvent which is not miscible with water, preferably, the alcohol solvent is selected from methanol, ethanol, 1-propanol, 2, propanol, n-butanol; the non-polar solvent which is not miscible with water is selected from dichloromethane, ethyl acetate, methyl acetate, cyclohexane or toluene.
The method for synthesizing astaxanthin by catalysis comprises the following steps: in the step 1), the solvent is ethanol and methylene dichloride with the mass ratio of 0.3-0.4:1, and the water content of the ethanol in the solvent is 8-10% by weight; the mass ratio of the solvent to the compound II is 4: 13-14.
The method for synthesizing astaxanthin by catalysis comprises the following steps: in the step 2), the strong alkali solution is dripped into the reaction mixture in the step 1) in a continuous mode, the reaction time of dripping the strong alkali solution into the reaction mixture in the step 1) is 4-10 hours, preferably 4-6 hours, and after dripping, the reaction is carried out at the temperature of minus 25 ℃ to minus 10 ℃ for 1-6 hours, preferably 3-5 hours.
The method for synthesizing astaxanthin by catalysis comprises the following steps: in step 3), the acid is 5% dilute sulfuric acid or glacial acetic acid, and the acid is neutralized to a pH value of 2-7, preferably 3-5.
The method for synthesizing astaxanthin by catalysis further comprises the following step 4): and 3) adding ethanol into the compound I obtained by concentrating the organic phase in the step 3), heating and refluxing for 3-4 hours, converting astaxanthin into a full- (E) -isomer through thermal isomerization, and then cooling, filtering and drying to obtain an astaxanthin finished product.
The invention provides a method for synthesizing astaxanthin by catalysis, which adopts weak alkali sodium formate, sodium acetate and sodium oxalate as phase transfer catalysts for wittig reaction, and H is removed in the reaction process + Firstly, reacting with weak base to generate corresponding weak acid, and promoting forward progress of wittig reaction; the weak acid then reacts with potassium hydroxide/sodium hydroxide to form the corresponding weak base. Compared with the prior art, the method has the following beneficial effects: (1) The new method uses weak alkali sodium formate, sodium acetate and sodium oxalate as phase transfer catalysts for wittig reaction, and has simple, safe and environment-friendly catalyst sources and lower economic cost; (2) Less by-products such as hemi-astaxanthin and astaxanthin are formed in the process of the present invention by the above preferred methodsThe technological conditions are that the content of the semi-astaxanthin and the astaxanthin is reduced to the minimum value, the content of the semi-astaxanthin is reduced to less than 0.9 percent, and the content of the astaxanthin is reduced to less than 0.4 percent, and (3) the technological conditions in the method are easier to control, and the condition requirements are simple. Astaxanthin obtained by the process of the present invention is largely converted into the particularly desirable all- (E) -isomer (all-trans astaxanthin) by thermal isomerisation (usually by heating in ethanol).
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present invention more clear, the technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is apparent that the described embodiments are some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
The molar yield of all-trans astaxanthin calculated on the basis of the compound III used = astaxanthin finished product mass x all-trans astaxanthin content/596.86 x 164/5.65
Comparative example 1
Preparing strong alkali liquor: 5.2g of sodium hydroxide was placed in a single-necked flask, 70g of ethanol (water content: 10 wt%) was added thereto, and the mixture was stirred and dissolved until the solution was transparent, and no significant sodium hydroxide remained, and transferred to a constant pressure dropping funnel.
At the beginning of the reaction, a 500ml four-necked flask was purged with nitrogen for at least 10min. Then, 40g of compound II, 5.65g of compound III, 100g of dichloromethane and 40g of ethanol (the water content is 10 wt%) are placed in a flask, when the mixed solution in the flask is cooled to-20 ℃, sodium hydroxide is dropwise added, the dropwise adding speed is controlled, the dropwise adding is carried out for 4 hours, after the dropwise adding is finished, stirring and heat preservation reaction are carried out at-15 ℃ for 3 hours, and the reaction process is monitored. After the reaction, neutralization was carried out with 7.8g of glacial acetic acid at constant temperature.
The neutralized reaction mixture was then washed 4 times with 200ml of water, respectively, and during the water washing, 50ml of dichloromethane were used for extraction each time, and the oil phase was separated off and collected. Concentrating the oil phase by vacuum distillation to recover 200-230ml dichloromethane, and stopping concentrating.
300ml of ethanol was added to the concentrated material, and the mixture was heated in a heating apparatus at 100 ℃. Then, 100ml of the solvent was extracted at an internal temperature of about 78℃and a heat source of 100℃and 100ml of ethanol was added thereto, followed by total reflux for 3 hours under boiling point conditions.
After total reflux, cooling the material to 20-30 ℃, carrying out suction filtration, flushing a filter cake with 50ml of ethanol for 2 times, and then placing the filter cake in a vacuum drying oven for drying for 6 hours to obtain 18.43g of astaxanthin finished product;
yield: according to high performance liquid chromatography detection, the product comprises: the total-trans astaxanthin content is 96.35%, the hemi-astaxanthin content is 1.21%, the astaxanthin content is 0.45%, and the cis-astaxanthin content is 0.45%; the molar yield of all-trans astaxanthin calculated on the basis of compound III was 86.36%
Comparative example 2 a 500ml four-necked flask was purged with nitrogen for at least 10 minutes. Then, 40g of compound II, 5.65g of compound III, 100g of dichloromethane, 40g of ethanol and 5.66g of sodium acetate were placed in a flask, and when the temperature of the mixed solution in the flask was reduced to-20 ℃, the reaction was kept at a temperature, and the reaction was monitored. Substantially non-reactive and no post-treatment was performed.
Example 1
Batch reaction material table
Preparing strong alkali liquor: 4.48g of sodium hydroxide was placed in a single-necked flask, 70g of ethanol (water content: 10%) was added thereto, and the mixture was stirred and dissolved until the solution was transparent, and no significant sodium hydroxide remained, and transferred to a constant pressure dropping funnel.
At the beginning of the reaction, a 500ml four-necked flask was purged with nitrogen for at least 10min. Then, 40g of compound II, 5.65g of compound III, 100g of dichloromethane, 40g of ethanol (water content of 10 wt%) and 5.74g of sodium acetate are placed in a flask, when the mixed solution in the flask is cooled to-20 ℃, the reinforced alkali solution is dripped, the dripping speed is controlled, after the dripping is finished, stirring and heat preservation reaction is continued for 3 hours at the temperature of less than-15 ℃, after the reaction is finished, 6.73g of glacial acetic acid is used for neutralization at the constant temperature.
The neutralized reaction mixture was then washed 4 times with 200ml of water, respectively, and during the water washing, 50ml of dichloromethane were used for extraction each time, and the oil phase was separated off and collected. Concentrating the oil phase by vacuum distillation to recover 200-230ml dichloromethane, and stopping concentrating.
300ml of ethanol was added to the concentrated material, and the mixture was heated in a heating apparatus at 100 ℃. Then, 100ml of the solvent was extracted at an internal temperature of about 78℃and a heat source of 100℃and 100ml of ethanol was added thereto, followed by total reflux for 3 hours under boiling point conditions.
After total reflux, cooling the materials to 20-30 ℃, carrying out suction filtration, flushing a filter cake with 50ml of ethanol for 2 times, and then placing the filter cake in a vacuum drying oven for drying for 6 hours; 20.07g of astaxanthin finished product is obtained
Yield: according to high performance liquid chromatography detection, the total-trans astaxanthin content in the product is 98.07%, the semi-astaxanthin content is 0.79%, the astaxanthin content is 0.23%, and the cis-astaxanthin content is 0.23%; the molar yield of all-trans astaxanthin calculated on the basis of the compound III used was 95.72%.
Monitoring the reaction processes of comparative examples 1, 2 and example 1, and comparing the influence of weak base on the reaction at-20 ℃ by taking sodium hydroxide as alkali, and finding that the reaction rate is relatively high and the trans-astaxanthin content is high by adding weak base into the mixed reaction solution; when the reaction liquid is only sodium hydroxide, the reaction rate is slower, and the trans-astaxanthin content is lower; when only weak base was added, C15 hardly reacted with C10.
Example 2
Batch reaction material table
Preparing strong alkali liquor: 5.04g of sodium hydroxide was placed in a single-necked flask, 80g of ethanol (water content: 8 wt%) was added thereto, and the mixture was stirred and dissolved until the solution was transparent, and no significant sodium hydroxide remained, and transferred to a constant pressure dropping funnel.
At the beginning of the reaction, a 500ml four-necked flask was purged with nitrogen for at least 10min. Then, 40g of compound II, 5.65g of compound III, 100g of dichloromethane, 40g of ethanol (water content of 8 wt%) and 3.81g of sodium oxalate are placed in a flask, when the mixed solution in the flask is cooled to-25 ℃, sodium hydroxide is dropwise added, the dropwise adding speed is controlled to be 4 hours, after the dropwise adding, stirring and heat preservation reaction are continued at the temperature of less than-20 ℃ for 3 hours, after the reaction is completed, 7.57g of glacial acetic acid is used for neutralization at a constant temperature.
The neutralized reaction mixture was then washed 4 times with 200ml of water, respectively, and during the water washing, 50ml of dichloromethane were used for extraction each time, and the oil phase was separated off and collected. Concentrating the oil phase by vacuum distillation to recover 200-230ml dichloromethane, and stopping concentrating
300ml of ethanol was added to the concentrated material, and the mixture was heated in a heating apparatus at 100 ℃. Then, 100ml of the solvent was extracted at an internal temperature of about 78℃and a heat source of 100℃and 100ml of ethanol was added thereto, followed by total reflux for 3 hours under boiling point conditions.
After total reflux, cooling the material to 20-30 ℃, carrying out suction filtration, flushing a filter cake with 50ml of ethanol for 2 times, and then placing the filter cake in a vacuum drying oven for drying for 6 hours to obtain 19.97g of astaxanthin finished product;
yield: according to high performance liquid chromatography detection, the total-trans astaxanthin content in the product is 97.85%, the hemi-astaxanthin content is 0.83%, the astaxanthin content is 0.21% and the cis-astaxanthin content is 0.36%; the molar yield of all-trans astaxanthin calculated on the basis of the compound III used was 95.03%
Example 3
Batch reaction material table
Preparing strong alkali liquor: 3.92g of sodium hydroxide was placed in a single-necked flask, 70g of ethanol (water content: 10 wt%) was added thereto, and the mixture was stirred and dissolved until the solution was transparent, and no significant potassium hydroxide remained, and transferred to a constant pressure dropping funnel.
At the beginning of the reaction, a 500ml four-necked flask was purged with nitrogen for at least 10min. Then, 40g of compound II, 5.65g of compound III, 100g of dichloromethane, 30g of ethanol (water content of 10 wt%) and 7.50g of sodium oxalate are placed in a flask, when the mixed solution in the flask is cooled to-15 ℃, potassium hydroxide is dropwise added, the dropwise adding speed is controlled for 4 hours, after the dropwise adding, stirring and heat preservation reaction are continued at the temperature of less than-10 ℃ for 3 hours, after the reaction is completed, 5.88g of glacial acetic acid is used for neutralization at a constant temperature.
The neutralized reaction mixture was then washed 4 times with 200ml of water, respectively, and during the water washing, 50ml of dichloromethane were used for extraction each time, and the oil phase was separated off and collected. Concentrating the oil phase by vacuum distillation to recover 200-230ml dichloromethane, and stopping concentrating
300ml of ethanol was added to the concentrated material, and the mixture was heated in a heating apparatus at 100 ℃. Then, 100ml of the solvent was extracted at an internal temperature of about 78℃and a heat source of 100℃and 100ml of ethanol was added thereto, followed by total reflux for 3 hours under boiling point conditions.
After total reflux, cooling the materials to 20-30 ℃, carrying out suction filtration, flushing a filter cake with 50ml of ethanol for 2 times, and then placing the filter cake in a vacuum drying oven for drying for 6 hours; 20.12g of astaxanthin product was obtained.
Yield: according to high performance liquid chromatography detection, the product contains 98.47% of all-trans astaxanthin, 0.64% of semi-astaxanthin, 0.18% of astaxanthin and 0.14% of cis-astaxanthin; the molar yield of all-trans astaxanthin calculated on the basis of the compound III used was 96.35%.
Example 4
Batch reaction material table
Preparing strong alkali liquor: 6.28g of potassium hydroxide was placed in a single-necked flask, 80g of ethanol (water content: 8 wt%) was added thereto, and the mixture was stirred and dissolved until the solution was transparent, and no significant potassium hydroxide remained, and transferred to a constant pressure dropping funnel.
At the beginning of the reaction, a 500ml four-necked flask was purged with nitrogen for at least 10min. Then, 40g of compound II, 5.65g of compound III, 100g of dichloromethane, 40g of ethanol (water content of 8 wt%) and 8.24g of potassium acetate are placed in a flask, when the mixed solution in the flask is cooled to-20 ℃, potassium hydroxide is dropwise added, the dropwise adding speed is controlled for 4 hours, after the dropwise adding, stirring and heat preservation reaction are continued at the temperature of less than-15 ℃ for 3 hours, after the reaction is completed, 6.73g of glacial acetic acid is used for neutralization at a constant temperature.
The neutralized reaction mixture was then washed 4 times with 200ml of water, respectively, and during the water washing, 50ml of dichloromethane were used for extraction each time, and the oil phase was separated off and collected. Concentrating the oil phase by vacuum distillation to recover 200-230ml dichloromethane, and stopping concentrating.
300ml of ethanol was added to the concentrated material, and the mixture was heated in a heating apparatus at 100 ℃. Then, 100ml of the solvent was extracted at an internal temperature of about 78℃and a heat source of 100℃and 100ml of ethanol was added thereto, followed by total reflux for 3 hours under boiling point conditions.
After total reflux, cooling the materials to 20-30 ℃, carrying out suction filtration, flushing a filter cake with 50ml of ethanol for 2 times, and then placing the filter cake in a vacuum drying oven for drying for 6 hours; 19.98g of astaxanthin product was obtained.
Yield: according to high performance liquid chromatography detection, the total trans-astaxanthin content of the product is 98.03%, the hemi-astaxanthin content is 0.76%, the astaxanthin content is 0.20% and the cis-astaxanthin content is 0.28%. The molar yield of all-trans astaxanthin calculated on the basis of the compound III used was 95.25%.
Claims (5)
1. A catalytic synthesis method of astaxanthin has the following reaction formula
Characterized in that the method comprises the steps of:
1) Dissolving a compound II and a compound III in a solvent, adding weak base, stirring, mixing and cooling at the temperature of-25 ℃ to-10 ℃;
the weak base is selected from one or more of sodium formate, sodium oxalate, sodium acetate, potassium formate, potassium oxalate and potassium acetate, the solvent is ethanol and methylene dichloride with the mass ratio of 0.3-0.4:1, and the water content of the ethanol is 8-10% by weight; the mass ratio of the solvent to the compound II is 4:13 to 14, wherein the molar ratio of the compound II to the compound III is 2.0 to 2.2:1, and the molar ratio of the weak base to the compound II is 0.5 to 1.5:1;
2) Dropping strong alkali solution into the reaction mixture of the step 1) in a continuous mode at the temperature of minus 25 ℃ to minus 10 ℃, wherein the reaction time of dropping strong alkali solution into the reaction mixture of the step 1) is 4 hours to 10 hours, and after dropping, the reaction is carried out for 3 hours to 5 hours at the temperature of minus 25 ℃ to minus 10 ℃; the strong alkali solution is a homogeneous solution or suspension of sodium hydroxide or potassium hydroxide in ethanol; the molar ratio of the alkali in the strong alkali solution to the compound II is 1.4-2.5:1, the water content of the ethanol in the prepared strong alkali solution is 8-10% by weight, and the mass ratio of the ethanol in the prepared strong alkali solution to the dichloromethane in the solvent is 0.7-0.8:1;
3) After the reaction is completed, adding acid for neutralization, extracting and separating, and concentrating an organic phase to obtain a compound I;
4): adding ethanol into the compound I obtained by concentrating the organic phase in the step 3), heating and refluxing for 3-4 hours, converting astaxanthin into a full- (E) -isomer through thermal isomerization, and then cooling, filtering and drying to obtain an astaxanthin finished product.
2. The method for catalytic synthesis of astaxanthin according to claim 1, wherein the molar ratio of alkali to compound II in the strong lye is 1.4-1.8:1.
3. The method for catalytic synthesis of astaxanthin according to claim 1, wherein the molar ratio of weak base to compound II is between 0.8 and 1.2:1.
4. the method for the catalytic synthesis of astaxanthin according to claim 1, wherein in step 2), the reaction time for dropping the strong base into the reaction mixture of step 1) is 4h to 6h.
5. The method for the catalytic synthesis of astaxanthin according to claim 1, wherein in step 3), the acid is 5% dilute sulfuric acid or glacial acetic acid, and is neutralized to a solution pH of 3-5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111569916.5A CN114369048B (en) | 2021-12-21 | 2021-12-21 | Method for catalytic synthesis of astaxanthin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111569916.5A CN114369048B (en) | 2021-12-21 | 2021-12-21 | Method for catalytic synthesis of astaxanthin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114369048A CN114369048A (en) | 2022-04-19 |
CN114369048B true CN114369048B (en) | 2023-12-26 |
Family
ID=81140773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111569916.5A Active CN114369048B (en) | 2021-12-21 | 2021-12-21 | Method for catalytic synthesis of astaxanthin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114369048B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115784957A (en) * | 2022-12-15 | 2023-03-14 | 上虞新和成生物化工有限公司 | Method for purifying astaxanthin |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0782246A (en) * | 1993-09-04 | 1995-03-28 | Basf Ag | Manufacturing of astaxanthin |
US5654488A (en) * | 1995-03-18 | 1997-08-05 | Basf Aktiengesellschaft | Preparation of astaxanthin |
CN101454280A (en) * | 2006-05-10 | 2009-06-10 | 帝斯曼知识产权资产管理有限公司 | Process for the preparation of as taxanthin |
JP2018131390A (en) * | 2017-02-13 | 2018-08-23 | アスタファーマシューティカルズ株式会社 | Method for producing optically active astaxanthin |
CN113461583A (en) * | 2021-07-06 | 2021-10-01 | 广州智特奇生物科技股份有限公司 | Synthetic method of astaxanthin |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060111580A1 (en) * | 2004-10-01 | 2006-05-25 | Lockwood Samuel F | Methods for the synthesis of chiral dihydroxy ketone intermediates useful for the chiral synthesis of carotenoids |
-
2021
- 2021-12-21 CN CN202111569916.5A patent/CN114369048B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0782246A (en) * | 1993-09-04 | 1995-03-28 | Basf Ag | Manufacturing of astaxanthin |
US5654488A (en) * | 1995-03-18 | 1997-08-05 | Basf Aktiengesellschaft | Preparation of astaxanthin |
CN101454280A (en) * | 2006-05-10 | 2009-06-10 | 帝斯曼知识产权资产管理有限公司 | Process for the preparation of as taxanthin |
JP2018131390A (en) * | 2017-02-13 | 2018-08-23 | アスタファーマシューティカルズ株式会社 | Method for producing optically active astaxanthin |
CN113461583A (en) * | 2021-07-06 | 2021-10-01 | 广州智特奇生物科技股份有限公司 | Synthetic method of astaxanthin |
Also Published As
Publication number | Publication date |
---|---|
CN114369048A (en) | 2022-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113511993B (en) | Synthesis method of beta-apo-8' -ethyl carotenoate | |
CN107056596B (en) | Preparation method of 2,6,11, 15-tetramethyl-2, 4,6,8,10,12, 14-hexadecaheptadien dialdehyde | |
CN114369048B (en) | Method for catalytic synthesis of astaxanthin | |
WO2007128574A1 (en) | Process for the preparation of astaxanthin | |
US3879424A (en) | Intermediate for the synthesis of zeaxanthins, xanthophylls, and 3-{62 -carotene | |
CN116082111B (en) | Method for synthesizing 1, 2-triarylethane | |
CN115141073B (en) | Preparation method of aromatic hydrocarbon dimer compound | |
CN103566972B (en) | A kind of Ferrocene oligomer and preparation method thereof | |
CN113956157B (en) | Method for synthesizing ethyl 2-formyl-1-cyclopropanecarboxylate | |
CN105646311B (en) | The method that one kind prepares the carrot aldehyde of β Apos 8 ' | |
CN111072450B (en) | Synthesis method of allyl alcohol derivative | |
US4064183A (en) | Synthesis of vitamin A, intermediates and conversion thereof to vitamin A | |
CN110128246B (en) | Preparation method of hydroxytyrosol | |
US4082791A (en) | Intermediates for vitamin a | |
CN111747876A (en) | Method for preparing astaxanthin by oxidizing canthaxanthin | |
CN114195681A (en) | Preparation method of 1,2, 3-tri (cyanoethoxy) propane | |
EP3207016A1 (en) | Method for producing specific alpha,beta-unsaturated aldehydes by rearrangement process | |
US4035425A (en) | Synthesis of Vitamin A, intermediates and conversion thereof to Vitamin A | |
CN112661624B (en) | Preparation method of m-phenoxy benzaldehyde | |
CN116199570B (en) | Preparation method of 2, 7-dimethyl-2, 4, 6-octatriene-1, 8-dialdehyde | |
US3947498A (en) | Vitamin A intermediates | |
CN115536494B (en) | Synthesis method of 1- (4-bromophenyl) -1, 4-butanediol | |
Stapp | Reaction of. alpha.-olefins with aqueous formaldehyde [yielding dioxanes and tetrahydropyranols] | |
CN101665427B (en) | Process for preparing 5-bromo-n-valeryl bromide | |
CN113880698B (en) | Preparation method of 9, 10-dibutoxyanthracene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |